Hollings C. Renton
Independent Member of Board of Directors
Mr. Renton retired from chairman of the board at Onyx Pharmaceuticals, Inc., a biopharmaceutical and biotherapeutics company, in March 2008, where he also served as president and chief executive officer from 1993 and as director from 1992. Prior to joining Onyx, Mr. Renton was the president and chief operating officer of Chiron Corporation, a pharmaceutical company. He assumed that position in 1991 on Chiron's acquisition of Cetus Corporation, a biotechnology company, where he had been president since 1990 and chief operating officer since 1987. He joined Cetus Corporation in 1981 and was chief financial officer from 1983 to 1987. Mr. Renton currently serves as the co-chair and lead director of Portola Pharmaceuticals, a pharmaceutical company, and as a member of the board of directors of Rigel Pharmaceuticals, a pharmaceutical company, Cepheid Corporation, a molecular diagnostics company, and the Special Olympics of Northern California. Mr. Renton holds a M.B.A. from the University of Michigan and a B.S. in mathematics from Colorado State University.